Author

Rizwan Romee

Dana-Farber Cancer InstituteORCID 0000-0001-9077-4736Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Jiahe LiiD· 2 shared Shaobo YangiD· 2 shared Zongqi WangiD· 2 shared Alaa Kassim AliiD· 1 shared Alice CheniD· 1 shared Andreia MaiaiD· 1 shared Andrew A. LaneiD· 1 shared Andrew J. AguirreiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Jiahe LiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintAug 20, 2026

Tumor-tropic E. coli engineered as living T and NK cell engagers

Shaobo Yang, Anna Clara Bader, Stephanie Sendker…·Rizwan Romee

This paper develops LIME, a bacterial platform that engagers T and NK cells to target tumors, showing enhanced cytotoxicity and immune response in preclinical models.

DOI 10.64898/2026.08.18.745642

mouseexperimental assay

𝕏 PostBluesky

Synthetic BiologybioRxivPreprintJun 11, 2026

Engineering tumor-homing bacteria as membrane-anchored immune checkpoint-blockade interfaces

Zongqi Wang, Chengyuan Fang, Xingwu Zhou…·Jiahe Li

This paper engineers tumor-homing bacteria to display immune checkpoint-blocking nanobodies, showing enhanced tumor suppression in mouse models compared to traditional antibody therapies.

1 citation

mouseexperimental assay

𝕏 PostBluesky